STOCKHOLM, April 24,
2024 /PRNewswire/ -- SciBase Holding
AB ("SciBase") (STO: SCIB), a leading developer of
augmented intelligence-based solutions for skin
disorders is pleased to announce a new partnership with Al
Shirawi Healthcare solutions, a leading distributor of medical
technologies across multiple specialities of aesthetics
dermatology, orthopedics and medical consumables In Dubai. Through
this partnership, Nevisense will now be available for patients in
the United Arab Emirates
(UAE).
Skin cancer is a growing problem in the UAE with official
statistics suggesting that skin cancer accounts for
about 14.5 per cent of cancer cases among males.
"We see the UAE as an attractive market with a passion for
state-of-the-art, groundbreaking technologies. Partnering up with a
well-resourced and knowledgeable ally will enable quick market
access at a low investment cost. We see this as a way to increase
our reach and help more people receive the best care possible,"
says Pia Renaudin, CEO at
SciBase
"SciBase is an ideal partner as their technology fits perfectly
with our goals and principles. We're dedicated to offering our
customers the best tools possible to improve patient care, and
Nevisense is a clear choice to help us achieve that," says
Ahmed Ismail. General manager at Al
Shirawi Healthcare solutions
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802,
e-mail: pia.renaudin@scibase.com
Certified Advisor (CA):
Vator Securities
Tel: +46 8 580 065 99
Email: ca@vatorsec.se
About Al Shirawi Healthcare solutions
Established to provide the Middle
East market with advanced medical technologies across
multiple specialities of aesthetics dermatology, orthopedics and
medical consumables, Al Shirawi Healthcare, a part of the reputed
Al Shirawi Group, provides an extensive array of turnkey solutions
that combine safety with efficacy to enable healthcare providers to
deliver a level of extraordinary care.
An ISO-certified company headquartered in the heart of
Dubai, Al Shirawi Healthcare is
powered by highly-skilled teams across Sales and specialised
Marketing, Regulatory Affairs, Customer Service and Coordination,
After Sales Services, Tendering, Training and Education Department
as well as a Quality Control and Auditing Department, enabling it
to meet and exceed client expectations through its unprecedented
in-house resources and commitment to excellence.
About SciBase:
SciBase is a global medical technology company, specializing in
early detection and prevention in dermatology. SciBase develops and
commercializes Nevisense, a unique point-of-care platform that
combines AI (artificial intelligence) and advanced EIS technology
to elevate diagnostic accuracy, ensuring proactive skin health
management.
Our commitment is to minimize patient suffering, allowing
clinicians to improve and save lives through timely detection and
intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in
dermatological advancements.
The company has been on the Nasdaq First North Growth Market
exchange since June 2, 2015. Learn
more at www.scibase.com. All press releases and financial reports
can be found here: http://investors.scibase.se/en/pressreleases
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/scibase/r/scibase-partners-with-al-shirawi-healthcare-solutions-to-offer-nevisense-in-uae,c3966401
The following files are available for download:
https://mb.cision.com/Main/12371/3966401/2753385.pdf
|
Dubai PR
final
|
View original
content:https://www.prnewswire.co.uk/news-releases/scibase-partners-with-al-shirawi-healthcare-solutions-to-offer-nevisense-in-uae-302125677.html